GUIDELINES FOR THE LIQUIDITY ENHANCEMENT SCHEME IN THE EQUITY CASH AND DERIVATIVES SEGMENTS HAVE BEEN UPDATED
SEBI, the market regulator, has eased the timeframe for the stock exchange to introduce a securities liquidity program. To boost the liquidity of illiquid assets, regulatory authorities permitted stock exchanges to establish liquidity enhancement programs in the equity cash and equity derivatives segments in 2014. The Indian Stock Exchange Commission decided to alter the framework based on the stock exchange’s experience.
According to SEBI, stock exchanges might implement liquidity-enhancing strategies on any securities under the new regulations. You can reapply the scheme with the same security if it is aborted. Previously, stock exchanges were authorized to implement three-year liquidity enhancement programs on any securities. The scheme can be reintroduced to the same security for less than three years after it was first launched for that security after it is discontinued.
The stock market board further stated that permission might be granted each year until the plan becomes active. The Board also monitors its execution and outcomes on a quarterly basis. Previously, the stock exchange’s board of directors had to approve liquidity plans in advance, and the board of directors had to evaluate their execution and outcomes regularly.
Brokers and other market intermediaries are given incentives for a set amount of time to bring liquidity and stimulate investor interest in securities with restricted trading activity under the liquidity enhancement program. increase.
REGISTRATION IS REQUIRED FOR A CHARITABLE TRUST RUNNING A MEDICAL STORE TO GIVE MEDICINES WITHOUT PROFIT
The Nagri Eye Research Foundation (“the Petitioner”) submitted an application for an advance ruling, whether a GST registration would be required for a medical shop it operates because the medical store would be selling drugs at a cheaper price.
The Petitioner was entitled to get GST Registration for the medical shop maintained by the Trust, and that the medical store selling drugs at a lesser rate amounted to supply of commodities, according to the AAR, Gujarat.
The Appellate AAR in Gujarat dismissed the appeal and upheld the findings of the AAR in Gujarat.
According to the Honourable Gujarat High Court, every supplier who is subject to Section 22(1) of the Central Goods and Services Tax Act, 2017 (“the CGST Act”) must register with the CGST Act. Furthermore, based on a co-joint interpretation of Section 7(1) of the CGST Act, the term “supply” covers all forms of supply of goods and services (or both) made or agreed to be supplied for consideration by a person in the conduct or furtherance of business. And, under Section 2(17) of the CGST Act, the term “business” refers to any trade or commerce, whether or not for a monetary gain. As a result, even if items are supplied at a lower rate, the Petitioner would be required to register for GST if the total turnover exceeds the threshold limit.